Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase-9

International Journal of Oncology

Volumn 44, Issue 1, 2014, Pages 309-318

  Jin, Mei Ling ^a   Park, Sun Young ^a   Kim, Younghun ^a   Park, Geuntae ^a   Lee, Sang Joon ^a  

^a Pusan National University   (South Korea)

Author keywords

Apoptosis; Halofuginone; Invasion; MMP 9; ROS

Indexed keywords

GELATIN; GELATINASE B; HALOFUGINONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CELL STRAIN MCF 7; DOWN REGULATION; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; METASTASIS; MIGRATION INHIBITION; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TUMOR INVASION; WESTERN BLOTTING; ZYMOGRAPHY;

APOPTOSIS; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; NF-KAPPA B; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINONES; TRANSCRIPTION FACTOR AP-1;

EID: 84891959842     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2157     Document Type: Article

References (36)

1. Liao YF, Rao YK and Tzeng YM: Aqueous extract of anisomeles indica and its purified compound exerts anti-metastatic activity through inhibition of NF-kappaB/AP-1-dependent MMP-9 activation in human breast cancer MCF-7 cells. Food Chem Toxicol 8: 2930-2936, 2012.
2. de Jonge MJ, Dumez H, Verweij J, et al: Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours. Eur J Cancer 12: 1768-1774, 2006.
3. Zcharia E, Atzmon R, Nagler A, Shimoni A, Peretz T, Vlodavsky I and Nagler A: Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor. Anticancer Drugs 10: 1022-1031, 2012.
4. Nagler A, Ohana M, Shibolet O, et al: Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone. Eur J Cancer 9: 1397-1403, 2004.
5. van Kempen LC, Rijntjes J, Mamor-Cornelissen I, et al: Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma. Int J Cancer 5: 1019-1029, 2008.
6. Leiba M, Jakubikova J, Klippel S, et al: Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents. Br J Haematol 6: 718-731, 2012.
7. Abramovitch R, Itzik A, Harel H, Nagler A, Vlodavsky I and Siegal T: Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model - an MRI study. Neoplasia 5: 480-489, 2004.
8. Na HK, Kim EH, Choi MA, Park JM, Kim DH and Surh YJ: Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. Biochem Pharmacol 10: 1241-1250, 2012.
9. Zhang Y, Luo M, Zu Y, et al: Dryofragin, a phloroglucinol derivative, induces apoptosis in human breast cancer MCF-7 cells through ROS-mediated mitochondrial pathway. Chem Biol Interact 2: 129-136, 2012.
10. Hegde M, Karki SS, Thomas E, et al: Novel levamisole derivative induces extrinsic pathway of apoptosis in cancer cells and inhibits tumor progression in mice. PLoS One 9: e43632, 2012.
11. Looi CY, Arya A, Cheah FK, et al: Induction of apoptosis in human breast cancer cells via caspase pathway by vernodalin isolated from centratherum anthelminticum (L.) seeds. PLoS One 2: e56643, 2013.
12. Li F, Li C, Zhang H, et al: VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells. Toxicol Appl Pharmacol 2: 217-226, 2012.
13. Artacho-Cordon F, Rios-Arrabal S, Lara PC, Artacho-Cordon A, Calvente I and Nunez MI: Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast radiotherapy. Surg Oncol 3: 143-151, 2012.
14. Yu HY, Kim KS, Moon HI, Kim KM, Lee YC and Lee JH: JNP3, a new compound, suppresses PMA-induced tumor cell invasion via NF-kappaB down regulation in MCF-7 breast cancer cells. Biochem Biophys Res Commun 2: 190-196, 2012.
15. Jin J, Cai L, Liu ZM and Zhou XS: miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev 6: 3681-3684, 2013.
16. Kim JM, Noh EM, Kwon KB, et al: Curcumin suppresses the TPA-induced invasion through inhibition of PKCalpha-dependent MMP-expression in MCF-7 human breast cancer cells. Phytomedicine 12: 1085-1092, 2012.
17. Ling H, Zhang Y, Ng KY and Chew EH: Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat 3: 609-620, 2011.
18. Juarez P, Mohammad KS, Yin JJ, et al: Halofuginone inhibits the establishment and progression of melanoma bone metastases. Cancer Res 23: 6247-6256, 2012.
19. Spector I, Zilberstein Y, Lavy A, Nagler A, Genin O and Pines M: Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice. PLoS One 7: e41833, 2012.
20. Bournine L, Bensalem S, Peixoto P, et al: Revealing the antitumoral effect of algerian glaucium flavum roots against human cancer cells. Phytomedicine 13: 1-8, 2013.
21. Liu JM, Pan F, Li L, et al: Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem Biophys Res Commun 1: 87-93, 2013.
22. Grudzien MM, Low PS, Manning PC, Arredondo M and Belton RJ Jr and Nowak RA: The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells. Fertil Steril 4: 1290-1298, 2010.
23. Chandra-Kuntal K, Lee J and Singh SV: Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic. Breast Cancer Res Treat 138: 69-79, 2013.
24. Shi X, Zhao Y, Jiao Y, Shi T and Yang X: ROS-dependent mitochondria molecular mechanisms underlying antitumor activity of pleurotus abalonus acidic polysaccharides in human breast cancer MCF-7 cells. PLoS One 5: e64266, 2013.
25. Huang P, Feng L, Oldham EA, Keating MJ and Plunkett W: Superoxide dismutase as a target for the selective killing of cancer cells. Nature 6802: 390-395, 2000.
26. Petanidis S, Kioseoglou E, Hadzopoulou-Cladaras M and Salifoglou A: Novel ternary vanadium-betaine-peroxido species suppresses H-ras and matrix metalloproteinase-2 expression by increasing reactive oxygen species-mediated apoptosis in cancer cells. Cancer Lett 2: 387-396, 2013.
27. Yang L, Wang P, Wang H, et al: Fucoidan derived from undaria pinnatifida induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells via the ROS-mediated mitochondrial pathway. Mar Drugs 6: 1961-1976, 2013.
28. Yang F, Chen WD, Deng R, et al: Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: hirsutanol A inhibits tumor growth through ROS production. J Transl Med 32: doi:10.1186/1479-5876-11- 32, 2013.
29. Chen HW, Chao CY, Lin LL, Lu CY, Liu KL, Lii CK and Li CC: Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells. Arch Toxicol 87: 857-869, 2013.
30. Lee WJ, Chen WK, Wang CJ, Lin WL and Tseng TH: Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 2: 178-191, 2008.
31. Chao CY, Lii CK, Hsu YT, Lu CY, Liu KL, Li CC and Chen HW: Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells. Carcinogenesis 34: 1843-1851, 2013.
32. Ma L, Lan F, Zheng Z, et al: Epidermal growth factor (EGF) and interleukin (IL)-1beta synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion. Mol Cancer 11: doi: 10.1186/1476-4598-11-79, 2012.
33. Liu PL, Tsai JR, Charles AL, et al: Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol Nutr Food Res 54: 196-204, 2010.
34. Li Y, Zhao H, Wang Y, et al: Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol Appl Pharmacol 13: 261-265, 2013.
35. Babu RL, Naveen Kumar M, Patil RH, Devaraju KS, Ramesh GT and Sharma SC: Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-jun, c-fos, and fra-1 in cell cycle regulation. Mol Cell Biochem 380: 143-151, 2013.
36. Hsieh CY, Tsai PC, Chu CL, Chang FR, Chang LS, Wu YC and Lin SR: Brazilein suppresses migration and invasion of MDA-MB-231 breast cancer cells. Chem Biol Interact 2: 105-115, 2013.